使用线粒体相关基因和结直肠癌单细胞测序数据开发一种新的预后预测模型
Shuang Xie1,2, Jixin Zhang2, Bo Sun1
1Department of General Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Translational gastroenterology and hepatology
|November 11, 2025
概括
这项研究开发了一个新的风险评分,使用五个线粒体基因来预测结直肠癌 (CRC) 患者的生存率. 该模型准确预测整体存活率 (OS),并强调线粒体基因在CRC进展中的作用.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 结肠直肠癌 (CRC) 是一个主要的全球健康问题,由于查的局限性,经常被诊断为迟.
- 线粒体功能障碍越来越多地被认为在癌症的发展和进展中的作用.
- 在CRC中特定线粒体基因的预后影响仍然不太清楚,造成了知识差距.
研究的目的:
- 系统地评估线粒体基因在结直肠癌中的预后价值.
- 开发和验证一种新的,可靠的风险评分模型,用于预测CRC患者的整体生存期 (OS).
- 确定与患者结果相关的关键线粒体基因.
主要方法:
- 利用了来自癌症基因组图谱 (TCGA) CRC队列的单细胞RNA测序 (scRNA-seq) 数据.
- 分析了来自MitoCarta 3.0的1,650个线粒体基因,使用差异基因表达,GSEA,途径和Cox回归分析.
- 在外部数据集 (GSE17536队列) 中验证了研究结果.
主要成果:
- 鉴定了具有预后意义的五个关键线粒体基因 (CPT2,ACSL6,MOCS1,TERT,PTRH1).
- 开发了一个风险评分系统,其中较高的分数与先进的临床特征和更差的生存率相关.
- 预测模型表现出强的性能,AUC分别为0.75,0.77,0.78为1年,3年和5年的OS预测.
- 风险评分与免疫微环境特征相关,进一步支持其预测能力.
结论:
- 基于线粒体基因的结直肠癌的新型预后模型已经建立.
- 该模型增强了对CRC进展机制的理解.
- 建议在更大的队列中进一步验证和在已识别的线粒体基因中探索治疗点.
更多相关视频
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...